Lessons From the Recent HCA 2022 General Meeting: Applying Single-Cell Data to Clinical Decision MakingSep 23 | Bio-IT World | Since mid-2021, many papers have described actionable links between genome-wide association studies and specific diseases based on single-cell data. But one associated challenge that comes up repeatedly is the handling, storing, and analyzing of the abundant data that is now available. More
- Sep 22 | Bio-IT World | At NVIDIA’s annual GTC event two days ago, the company made two particular announcements key to the life sciences space. First, NVIDIA announced it will make Clara Parabricks available on the Broad Institute’s Terra cloud platform. Second, the company revealed plans to expand large language models to biology, announcing BioNeMo. More
- Sep 21 | Bio-IT World | Bio-IT World is heading to Berlin next month to explore biotech advancements happening in Europe. With five conference tracks, a plenary program, and an exhibit hall we are making the most of the packed two days of scientific content and industry best practices. Here are just a few of the presentations and themes flagged thus far. More
- Sep 20 | Bio-IT World | Tel Aviv University researchers discovered that glioblastoma cells—a highly resistant, aggressive, and deadly form of cancer—“starve” to death without immunometabolic support from astrocytes. More
- Sep 15 | Bio-IT World | The greater New York metropolitan area is the epicenter of an ambitious human genome sequencing research project newly launched by Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai. If the vision is realized, Mount Sinai will enroll a million patients into a study over the next five years that will sequence and analyze the DNA in their blood to tease out the role of genetics and environment on health. More
- Sep 14 | Bio-IT World | In the ongoing debate about whether biospecimens should be covered by human subjects research regulations, bioethicists at the University of Michigan recently added a critical datapoint in disproving one of the arguments—namely, that the public feels more protective of their biospecimens than their health information. More
- Sep 13 | Bio-IT World | The University of Calgary research team discovered that neutrophils and monocytes—two types of white blood cells—play distinct roles in wound healing, with digestive hormones contributing to immune function. More
- Sep 08 | Bio-IT World | Walter and Eliza Hall Institute geneticists recently discovered that epigenetic information passes from murine mother to child and has lasting effects on development and growth. More
- Sep 07 | Bio-IT World | Researchers at Tulane University and Ochsner Health have characterized carotid plaque taken from patients within days of a stroke, confirming that ruptures are associated with the thinning of the fibrous cap stabilizing the fatty deposits as well as suggesting that B cells play a bigger role than has previously been appreciated. More
- Sep 06 | Bio-IT World | The International Organization for Standardization has released the genome editing standard vocabulary, comprising 42 terms and definitions covering genome editing concepts, tools, and outcomes. Samantha Maragh, leader of the Genome Editing Program at the National Institute of Standards and Technology, says the goal now is adoption. More
Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and
data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!
Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.